About this Immunology and Microbiology article

Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial by Loret, Erwann P.; Darque, Albert; Jouve, Elisabeth; Loret, Elvenn A.; Nicolino-Brunet, Corinne; Morange, Sophie; Castanier, Elisabeth; Casanova, Josiane; Caloustian, Christine; Bornet, Charléric; Coussirou, Julie; Boussetta, Jihen; Couallier, Vincent; Blin, Olivier; Dussol, Bertrand; Ravaux, Isabelle is a Immunology and Microbiology article available to read on EtoBox.

Author

Loret, Erwann P.; Darque, Albert; Jouve, Elisabeth; Loret, Elvenn A.; Nicolino-Brunet, Corinne; Morange, Sophie; Castanier, Elisabeth; Casanova, Josiane; Caloustian, Christine; Bornet, Charléric; Coussirou, Julie; Boussetta, Jihen; Couallier, Vincent; Blin, Olivier; Dussol, Bertrand; Ravaux, Isabelle

Publisher

BioMed Central; Springer (Biomed Central Ltd.); [London]: BioMed Central, c2004-; Springer Science and Business Media LLC; Society for Mining, Metallurgy and Exploration Inc. (ISSN 1742-4690)

Published

2016

Field

Immunology and Microbiology (Life Sciences)